Global Blood Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
03 Mar 2022	Form 3: Habibizad Nazila, See Remarks Holds 27,960 shares of Common Stock
03 Aug 2021	Form 3: Krehlik Carrie, Chief Human Resources Officer No securities owned
07 May 2021	Form 3: Smith-Whitley Kim, See Remarks No securities owned
19 Mar 2021	Form 3: Thompson Alexis A., Director No securities owned
01 Jun 2020	Form 3: Patrick Deval L, Director No securities owned
03 Oct 2019	Form 3: Lehrer-Graiwer Joshua, Chief Medical Officer
12 Aug 2019	Form 3: Fink Eric, Chief Human Resources Officer No securities owned
05 Mar 2019	Form 3: Cathers Brian Edwin, Chief Scientific Officer No securities owned
21 Dec 2018	Form 3: Svoronos Dawn, Director No securities owned
14 Mar 2018	Form 3: Johnson David Lee, Chief Commercial Officer
13 Feb 2018	Form 3: Calhoun Lesley Ann, See Remarks Holds 0 shares of Common Stock
22 Dec 2017	Form 3: Yarno Wendy L, Director No securities owned
15 Dec 2017	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 4,714,066 shares of Common Stock
12 Oct 2016	Form 3: Suvari Tricia Borga, Chief Legal Officer No securities owned
04 Apr 2016	Form 3: Farrow Jeffrey S, Chief Financial Officer
10 Feb 2016	Form 3: Pierce Glenn, Director No securities owned
10 Feb 2016	Form 3: Bonney Michael W, Director No securities owned
04 Jan 2016	Form 3: Morrison Scott W, Director No securities owned
24 Sep 2015	Form 3: Pizzo Philip A., Director No securities owned
11 Aug 2015	Form 3: Third Rock Ventures II, L.p., 10% owner and 7 others Holds 571,428 shares of Common Stock

Comments